Interleukin-1(IL-1),referred to as two distinct proteins,IL-1αand IL-1β,was first described almost 50 years ago.1 IL-1αand IL-1βrepresent immediate early innate cytokines critically involved in alarming and activa...Interleukin-1(IL-1),referred to as two distinct proteins,IL-1αand IL-1β,was first described almost 50 years ago.1 IL-1αand IL-1βrepresent immediate early innate cytokines critically involved in alarming and activating the host defense system.2 Therefore,any impairment of IL-1 signaling pathways often leads to devastating outcomes,such as autoimmunity and autoinflammation,dysmetabolism,cardiovascular disorders,and cancer.2 Many advances in targeting IL-1 in immune therapies have been achieved;for example,the IL-1-blocking agents anakinra(IL-1 receptor antagonist,IL-1Ra),canakinumab(anti-IL-1βmAb),and MABp1(anti-IL-1αmAb)have been approved for clinical use or are being evaluated.2 Remarkably,the CANTOS study,which included over 10,000 patients,showed that blocking IL-1βnot only reduced atherosclerosis-related cardiovascular mortality but was also effective in inflammatory diseases related to lung cancer,arthrosis,and gout.3.展开更多
文摘Interleukin-1(IL-1),referred to as two distinct proteins,IL-1αand IL-1β,was first described almost 50 years ago.1 IL-1αand IL-1βrepresent immediate early innate cytokines critically involved in alarming and activating the host defense system.2 Therefore,any impairment of IL-1 signaling pathways often leads to devastating outcomes,such as autoimmunity and autoinflammation,dysmetabolism,cardiovascular disorders,and cancer.2 Many advances in targeting IL-1 in immune therapies have been achieved;for example,the IL-1-blocking agents anakinra(IL-1 receptor antagonist,IL-1Ra),canakinumab(anti-IL-1βmAb),and MABp1(anti-IL-1αmAb)have been approved for clinical use or are being evaluated.2 Remarkably,the CANTOS study,which included over 10,000 patients,showed that blocking IL-1βnot only reduced atherosclerosis-related cardiovascular mortality but was also effective in inflammatory diseases related to lung cancer,arthrosis,and gout.3.
